Skip to main content

Acusphere Stock Forecast, Price & News

+0.01 (+32.35 %)
(As of 05/17/2021 11:38 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume14,030 shs
Average Volume19,977 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ACUS News and Ratings via Email

Sign-up to receive the latest news and ratings for Acusphere and its competitors with MarketBeat's FREE daily newsletter.

Acusphere logo

About Acusphere

Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts.


Curis Inc
Curis Inc
January 29, 2021 |
Acusphere Inc
Acusphere Inc
January 16, 2021 |
See More Headlines

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:ACUS
Year FoundedN/A

Sales & Book Value

Annual SalesN/A





Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.00 out of 5 stars

Medical Sector

2006th out of 2,032 stocks

Pharmaceutical Preparations Industry

765th out of 768 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Acusphere (OTCMKTS:ACUS) Frequently Asked Questions

What stocks does MarketBeat like better than Acusphere?

Wall Street analysts have given Acusphere a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Acusphere wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Acusphere's key executives?

Acusphere's management team includes the following people:
  • Dr. William I. Ramage D.Phil, Chief Devel. Officer (Age 67, Pay $225.09k)

Who are some of Acusphere's key competitors?

What is Acusphere's stock symbol?

Acusphere trades on the OTCMKTS under the ticker symbol "ACUS."

How do I buy shares of Acusphere?

Shares of ACUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Acusphere's stock price today?

One share of ACUS stock can currently be purchased for approximately $0.05.

What is Acusphere's official website?

The official website for Acusphere is

Where are Acusphere's headquarters?

Acusphere is headquartered at 500 ARSENAL ST, WATERTOWN MA, 02472.

How can I contact Acusphere?

Acusphere's mailing address is 500 ARSENAL ST, WATERTOWN MA, 02472. The company can be reached via phone at 617-648-8800 or via email at [email protected]

This page was last updated on 5/18/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.